Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cg Oncology Inc shares valued at $28,000 were sold by POST LEONARD E on May 21 ’25. At $28.00 per share, POST LEONARD E sold 1,000 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, POST LEONARD E sold 1,000 shares, netting a total of over 30,760 in proceeds. Following the sale of shares at $30.76 each, the insider now holds 0 shares.
Before that, POST LEONARD E had sold 1,000 shares from its account. In a trade valued at $28,000, the Director traded Cg Oncology Inc shares for $28.00 each. Upon closing the transaction, the insider’s holdings decreased to 1,000 shares, worth approximately $0.0.
As published in their initiating research note from JP Morgan on May 02, 2025, Cg Oncology Inc [CGON] has been an Overweight and the price target has been revised to $41. Analysts at Scotiabank started covering the stock with ‘”a Sector perform”‘ outlook in a report released in mid April. As of January 07, 2025, TD Cowen has initiated its “Buy” rating for CGON. Earlier on October 24, 2024, UBS initiated its rating. Their recommendation was “a Buy” for CGON stock.
Analyzing CGON Stock Performance
During the last five days, there has been a surge of approximately 0.04%. Over the course of the year, Cg Oncology Inc shares have dropped approximately -8.54%. Shares of the company reached a 52-week high of $32.30 on 04/28/25 and a 52-week low of $14.80 on 04/09/25.
Support And Resistance Levels for Cg Oncology Inc (CGON)
According to the 24-hour chart, there is a support level at 25.47, which, if violated, would cause prices to drop to 24.72. In the upper region, resistance lies at 26.79. The next price resistance is at 27.36. RSI (Relative Strength Index) is 56.14 on the 14-day chart, showing neutral technical sentiment.
